Target Healthcare REIT (LON:THRL) Reaches New 12-Month High – What’s Next?

Target Healthcare REIT (LON:THRL – Get Free Report)’s share price hit a new 52-week high on Friday. The stock traded as high as GBX 117 and last traded at GBX 114.34, with a volume of 86795 shares traded. The stock had previously closed at GBX 112.80.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reissued a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a research report on Wednesday, August 5th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of GBX 101.

Get Our Latest Analysis on THRL

Target Healthcare REIT Stock Performance

The stock has a market capitalization of £702.11 million, a PE ratio of 9.01, a PEG ratio of 1.48 and a beta of 0.71. The stock has a 50-day moving average price of GBX 112.11 and a two-hundred day moving average price of GBX 108.36.

Target Healthcare REIT (LON:THRL – Get Free Report) last announced its quarterly earnings data on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 11.03% and a net margin of 114.60%. As a group, equities analysts predict that Target Healthcare REIT will post 6.2219101 earnings per share for the current year.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Further Reading

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.